Ongoing Clinical Trials and the Potential Therapeutics for COVID-19 Treatment

Hossein Abolhassani; Ghazal Bashiri; Mahdi Montazeri; Hasan Kouchakzadeh; Seyed Abbas Shojaosadati; Seyed Ehsan Ranaei Siadat

doi:10.1007/978-981-16-3108-5_2

BOOK-CHAPTER

Ongoing Clinical Trials and the Potential Therapeutics for COVID-19 Treatment

Hossein Abolhassani Ghazal Bashiri Mahdi Montazeri Hasan Kouchakzadeh Seyed Abbas Shojaosadati Seyed Ehsan Ranaei Siadat

Year: 2021 Pages: 27-89

DOI: 10.1007/978-981-16-3108-5_2

Get Full-Text PDF Get Analytical Report

Keywords:

Favipiravir Medicine Lopinavir Disease Ribavirin Convalescent plasma Clinical trial Pharmacology Ebola virus Immune system Monoclonal antibody Immunology Virology Coronavirus disease 2019 (COVID-19) Intensive care medicine Virus Antibody Infectious disease (medical specialty) Internal medicine

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

386

Refs

0.17

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

COVID-19 Clinical Research Studies

Health Sciences → Medicine → Infectious Diseases

SARS-CoV-2 and COVID-19 Research

Health Sciences → Medicine → Infectious Diseases

Long-Term Effects of COVID-19

Health Sciences → Medicine → Neurology

Ongoing Clinical Trials and the Potential Therapeutics for COVID-19 Treatment

Metrics

Topics

Related Documents

Clinical Trials of COVID-19 Therapeutics and Vaccines

COVID-19: An Update on therapeutics and Clinical trials

Clinical trials are gasping during the ongoing COVID-19 pandemic

Ongoing COVID-19 Clinical Trials: A Pharmacological Perspective on Pneumonia

Ongoing COVID-19 Clinical Trials: A Pharmacological Perspective on Pneumonia